News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Novel Stent-Based Technologies Could Prove Viable Alternatives For Aneurysm And Stroke Treatment, Says GlobalData Analyst



3/20/2014 11:28:38 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

LONDON, UK (GlobalData), 20 March 2014 - Among the various neurointerventional devices that have been developed for challenging indications, such as intracranial aneurysms and acute ischemic stroke (AIS), flow diverters and stent retrievers have shown particular promise as viable treatment alternatives, although they have yet to prove their long-term effectiveness, says an analyst with research and consulting firm GlobalData.

Priya Madhavan, MS, GlobalData's Analyst covering Medical Devices, states that following the success of stent-based technologies in the interventional cardiology and endovascular therapy fields, flow diverters, such as the Pipeline Embolization Device, and stent retrievers, including Solitaire, have attracted attention from the neurointerventional community.

Madhavan says: “Flow diversion techniques can be employed to treat complex intracranial aneurysms, including wide-neck, large and giant aneurysms, which remain difficult to treat due to high recanalization and recurrence rates. Flow diversion devices aim to reduce the need for inserting multiple coils and using stent- and balloon-assisted devices. “However, while this is a promising technique for otherwise untreatable aneurysms, we do not believe that the technology will replace embolic coils. We predict the flow diverter market to reach revenues of $200 million by 2020, which is more than two-fold lower than the embolic coil market.”

Meanwhile, the development of novel mechanical thrombectomy devices, such as stent retrievers, has been fuelled by the limitations of intravenous thrombolysis with recombinant tissue plasminogen activator.

Stent retrievers provide a one-step technique for device deployment and clot retrieval, which increases ease of use and patient safety. With the development of innovative stent-retriever technologies, market sales of mechanical thrombectomy devices, such as the MERCI clot retrieval system, have decreased significantly. GlobalData forecasts the stent retriever market to achieve revenues of over $50 million by 2020 and gain the largest share in the mechanical thrombectomy devices arena.

Madhavan concludes: “Despite the enthusiasm elicited by these stent-based devices, we have a long way to go before they become the standard treatment for neurovascular applications, as we first need to see long-term, robust data demonstrating their clinical effectiveness. Performance and quality standards also need to be established and treatment costs reduced, to enable widespread adoption of these devices in the future.”

- Comments provided by Priya Madhavan, MS, GlobalData's Analyst covering Medical Devices.

For guidelines on how to cite GlobalData, please see: http://www.globaldata.com/QuotingGlobalData.aspx

-ABOUT GLOBALDATA-

GlobalData is a leading global research and consulting firm offering advanced analytics to help clients make better, more informed decisions every day. Our research and analysis is based on the expert knowledge of over 700 qualified business analysts and 25,000 interviews conducted with industry insiders every year, enabling us to offer the most relevant, reliable and actionable strategic business intelligence available for a wide range of industries.

For more information, please contact our Press Office on +44 (0)1204 543 537 or at pr@globaldata.com.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES